◼ Archived
Health
🔮 fades ✓
The Difficulty of Diagnosing Anorexia in the GLP-1 Era
4 news sources are covering this Health story right now — Archynetys is tracking how fast it spreads.
Weight Loss Drugs
42 independently detected trends connected to this subject, with the latest coverage first.
What Archynetys tracks about Weight Loss Drugs
This hub groups 42 separate news trends connected to Weight Loss Drugs, spanning June 21, 2026 through October 17, 2026. Each event page combines source coverage, attention velocity and a time-stamped explanation instead of treating every headline as a separate story.
The record below represents 349 article observations and 326 source signals, led by Health, Business coverage. Use it to compare how individual events emerged, spread and changed over time.
◼ Archived
Business
🔮 fades ✓
High cost of GLP-1s drives some to seek cheaper, unregulated versions
15M Americans take GLP-1 drugs, with some seeking cheaper alternatives due to high costs.
◼ Archived
Health
🔮 fades ✓
Some who take GLP-1s are suffering serious side effects, but it's unclear how often
Some who take GLP-1s are suffering serious side effects, but it's unclear how often.
◼ Archived
Health
🔮 fades ✓
Probing the many benefits of GLP-1 receptor agonists
6 news sources are covering this Health story right now — Archynetys is tracking how fast it spreads.
◼ Archived
Health
🔮 fades ✓
Nail detachment over four times more common among GLP-1 users, first controlled study finds
5 news sources are covering this Health story right now — Archynetys is tracking how fast it spreads.
◼ Archived
Health
🔮 fades ✓
Does GLP-1 use result in significant hair loss?
11 news sources are covering this Health story right now — Archynetys is tracking how fast it spreads.
◼ Archived
Business
🔮 fades ✓
Some GLP-1 companies facing lawsuits over vision loss. What to know
7 news sources are covering this Business story right now — Archynetys is tracking how fast it spreads.
◼ Archived
Health
🔮 fades ✓
Nearly 1 in 6 Kids on GLP-1s Developed This Problem Within a Year
Study finds link between GLP-1 drugs and nutritional deficiencies in children
◼ Archived
Health
🔮 fades ✓
The dangerous risks of stopping Ozempic and GLP-1s
18 news sources are covering this Health story right now — Archynetys is tracking how fast it spreads.
◼ Archived
Business
🔮 fades ✓
Will Wegovy Be A Part D, A Medicare GLP-1 Bridge Drug Or Neither?
5 news sources are covering this Business story right now — Archynetys is tracking how fast it spreads.
◼ Archived
Health
🔮 fades ✓
GLP-1-driven vitamin deficiency linked to rare brain disorder: Study
9 news sources are covering this Health story right now — Archynetys is tracking how fast it spreads.
◼ Archived
Health
🔮 fades ✓
Obesity science, research gaps, and opportunities in the new era of obesity medicines: an Endocrine Society scientific statement
New era of obesity medicines raises hopes for broader health benefits beyond weight loss.
◼ Archived
Health
🔮 fades ✓
Popular GLP-1 drugs may trigger a rare, life-threatening brain disorder: study
Popular GLP-1 drugs linked to life-threatening brain disorder and suicidal thoughts after weight regain.
◼ Archived
Health
🔮 fades ✓
GLP-1 weight-loss drugs show promise for sleep apnea
GLP-1 weight-loss drugs could cut sleep-apnea rates, opening a new market and clinical pathway for millions.
◼ Archived
Health
🔮 fades ✓
Cravings ‘like heroin withdrawal’: what happens when weight-loss drugs don’t work?
Weight-loss drugs not working as expected lead to withdrawal-like cravings and unexpected side effects.
◼ Archived
Health
🔮 fades ✓
More children under 12 in US are being prescribed weight-loss drugs, study finds
US prescriptions for weight-loss drugs in children under 12 are increasing, according to a recent study.
◼ Archived
Health
🔮 fades ✓
GLP-1 medications may worsen or speed hair loss in some men, study finds
GLP-1 medications may worsen or speed hair loss in some men, study finds.
◼ Archived
Business
🔮 fades ✓
Ozempic Maker Novo Nordisk’s Investors Are Nervously Looking Into the Future
Investors in Novo Nordisk are on edge as the pharmaceutical giant faces increasing competition in the GLP-1 market.
◼ Archived
Health
Ozempic may help people with serious mental health condition: study
People with serious mental health conditions may soon have a new treatment option.
◼ Archived
Health
🔮 fades ✓
Unexpected GLP-1 side effect? Studies show the meds may help people with addictions
GLP-1 medications, known for weight loss, are now being studied for their potential to treat addictions.
◼ Archived
Health
New Research Shows a Strong Link Between This GLP Medication and Hair Loss. Experts Weigh In.
New research has linked a popular GLP medication to increased hair loss, sparking discussions among health experts.
◼ Archived
Health
🔮 fades ✓
GLP-1s Left Their Hair 'Falling Out In Fistfuls'
Recent reports indicate that users of GLP-1 receptor agonists are experiencing significant hair loss, sparking medical interest in these medications.
◼ Archived
Health
🔮 fades ✓
Researchers examine unanticipated benefits of GLP-1 medications
Researchers are finding new benefits of GLP-1 medications, shifting the conversation beyond weight loss.
◼ Archived
Business
Eli Lilly is suing six companies over illegal sales of its unapproved weight loss drug
Eli Lilly is suing six companies to stop illegal sales of its unapproved weight loss drug, retatrutide.
◼ Archived
Business
🔮 fades ✓
Eli Lilly takes aim at illicit market for its experimental weight-loss drug
Eli Lilly is suing companies over the illegal sales of its experimental weight-loss drug, retatrutide.
◼ Archived
Health
🔮 fades ✓
Death of law student linked to popular weight loss shot
A 19-year-old law student has died following the use of the weight loss drug Tirzepatide, prompting an official coroner's inquest.
◼ Archived
Health
🔮 fades ✓
Nearly 200 deaths linked to weight-loss drugs Ozempic and Mounjaro in the UK
Nearly 200 deaths in the UK have been linked to popular weight-loss drugs Ozempic and Mounjaro, raising urgent questions about their safety.
◼ Archived
Business
🔮 fades ✓
Amazon to Offer GLP-1 Weight-Loss Drugs to Medicare Part D Patients
Amazon Pharmacy is now delivering GLP-1 weight-loss drugs to Medicare patients for $50 a month.
◼ Archived
Business
🔮 fades ✓
Eli Lilly Posts Higher Revenue on Continued GLP-1 Demand
Eli Lilly's stock surges as demand for its weight-loss drugs continues to drive revenue growth.
◼ Archived
Business
🔮 fades ✓
Lilly reports second-quarter 2026 financial results, raises full-year guidance, and highlights continued growth and pipeline progress
Divergent earnings reports this week reveal a surge in pharmaceutical demand alongside cooling momentum in the digital advertising sector.
◼ Archived
Health
🔮 fades ✓
Popular weight-loss drugs may help protect against a deadly disease, doctor says
A doctor's remarks have sparked a wave of interest in the potential cancer-fighting benefits of popular weight-loss drugs.
◼ Archived
Health
🔮 fades ✓
I Spent 8 Weeks On A GLP-1s, And Honestly? It Wasn't At All What Social Makes It Seem Like
5 news sources are covering this Health story right now — Archynetys is tracking how fast it spreads.
◼ Archived
Business
🔮 fades ✓
Compounded GLP-1 drugs creating concern among doctors and FDA
Six outlets report that the FDA is scrutinizing compounded GLP-1 drugs, raising concerns among doctors about potential health risks.
◼ Archived
Health
🔮 fades ✓
Rare eye disorder linked to Ozempic-like medications
Health regulators and legal firms are responding to a linked risk of rare blindness and eye disorders associated with GLP-1 weight-loss medications.
◼ Archived
Health
🔮 fades ✓
Pharmacists Warn About Diet on Weight Loss Drugs
Pharmacists and health outlets are highlighting the critical role of specific nutrition strategies for patients prescribed GLP-1 weight loss medications.
◼ Archived
Health
🔮 fades ✓
Weight loss drugs linked to increased risk of hair loss, researchers say
14 news sources are covering this Health story right now — Archynetys is tracking how fast it spreads.
◼ Archived
Health
🔮 fades ✓
People Can Lose Their Zest for Life After Starting GLP-1s, Docs Warn
Medical professionals are warning that GLP-1 medications may lead to emotional flatness and a loss of "zest for life" alongside weight loss.
◼ Archived
Health
🔮 fades ✓
Stronger than Ozempic. Not exactly legal. ‘Reta’ has entered the chat.
An unapproved weight-loss drug is gaining attention for its powerful effects and potential health risks.
◼ Archived
Health
🔮 holds ✗
As weight loss drugs like Ozempic spread, Louisiana doctors, researchers help answer big questions
Researchers and doctors are exploring the broader implications of GLP-1 weight loss drugs as their use becomes more widespread.
◼ Archived
Health
🔮 fades ✓
Weight‑loss drugs like Ozempic could work for addiction too—and we finally know how
Research suggests weight-loss drugs like Ozempic may also help treat addiction.
◼ Archived
Business
🔮 fades ✓
Trump may be mystery patient in odd case of 79yo getting experimental obesity drug
Speculation swirls around a 79-year-old patient who received an experimental weight loss drug, with former President Trump as the suspected recipient.
◼ Archived
Health
🔮 fades ✓
Medicare launches pilot program expanding access to GLP-1 drugs
Medicare's new pilot program expands access to GLP-1 drugs, sparking coverage on eligibility and potential impacts.